Molecular Cancer Therapeutics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gupta, S.
Right arrow Articles by Gollapudi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gupta, S.
Right arrow Articles by Gollapudi, S.
Vol. 2, 711-719, August 2003     Molecular Cancer Therapeutics
© 2003 American Association for Cancer Research

Arsenic Trioxide Induces Apoptosis in Peripheral Blood T Lymphocyte Subsets by Inducing Oxidative Stress: A Role of Bcl-2

Sudhir Gupta1, Leman Yel, Daniel Kim, Choong Kim, Sujata Chiplunkar and Sastry Gollapudi

Cellular and Molecular Immunology and Molecular Biology Laboratories, Division of Basic and Clinical Immunology, University of California, Irvine, California 92697

1 To whom requests for reprints should be addressed, at Medical Sciences I, C-240, University of California, Irvine, CA 92697/ Phone: (949) 824-5818; Fax: (949) 824-4362; E-mail: sgupta{at}uci.edu

Arsenic trioxide (As2O3) has been used successfully in the treatment of acute promyelocytic leukemia. However, effects of As2O3 in normal peripheral blood T cells have not been studied in detail. The purpose of this study was to investigate whether As2O3 would induce apoptosis in normal T cells and therefore may have immunosuppressive side effects. Apoptosis was measured by terminal deoxynucleotidyl transferase-mediated nick end labeling assay, caspase activation by flow cytometry and colorimetric assay, mitochondrial transmembrane potential ({Delta}{psi}m), intracellular reactive oxygen species (ROS), and intracellular reduced glutathione (GSH) by flow cytometry. The release of cytochrome c and apoptosis-inducing factor (AIF) from the mitochondria was measured by confocal microscopy, and the expression of molecules regulating apoptosis was measured by Western blotting. As2O3, at clinically achievable therapeutic concentrations, induces apoptosis in peripheral blood T cells. As2O3-induced apoptosis was associated with reduced {Delta}{psi}m, enhanced generation of intracellular ROS, decreased levels of intracellular GSH, release of cytochrome c and AIF from the mitochondria, activation of caspases, down-regulation of Bcl-2 and Bcl-xL, and up-regulation of Bax expression. In addition, exogenous GSH protected lymphocytes from As2O3-induced apoptosis. Furthermore, overexpression of Bcl-2 inhibited As2O3-induced apoptosis and blocked depolarization of {Delta}{psi}m, generation of ROS, and release of both cytochrome c and AIF. These data indicate that As2O3 induces apoptosis in T cells by enhancing oxidative stress and that Bcl-2 appears to play a major role in As2O3-induced apoptosis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.